Precision medicine envisions a future where health care is tailored to the unique molecular identity of each individual. However, for decades, a fundamental biological reality has obscured this approach: the profound cellular heterogeneity within every patient. Traditional bulk analytical methods, which average molecular signals across millions of cells, paint a blurred, low-resolution picture of disease, masking the rare but critical cell populations that drive pathogenesis, therapy resistance, and relapse. This chapter charts the revolution that is enabled by single-cell analysis (SCA), a suite of revolutionary technologies that finally brings this cellular mosaic into sharp focus. The core principles of SCA, including the detection and barcoding of molecular contents from individual cells, have evolved into high-throughput platforms for genomics, transcriptomics, epigenomics and proteomics. The chapter details how this immense data is tamed by sophisticated computational biology and artificial intelligence approaches, which translates complex datasets into discoverable patterns of cell types, states, and trajectories. Significantly, the important clinical impacts of this technology, from predicting cancer relapse by tracking clonal evolution to identifying the specific neuronal subtypes vulnerable in Alzheimer’s disease, have been reported. Still, this approach is not without its challenges. Moreover, the technical, economical, and ethical barriers that must be resolved for rightful integration into clinical practice have been discussed. In conclusion, single-cell analysis goes beyond simply providing new tools. It fundamentally reframes the understanding of biology, affirming that cellular heterogeneity is the central idea that must be decoded. By continuing to unravel this intricate topic, the idea of providing the right treatment to a specific patient at the right time is steadily transitioning from an ideal approach into an achievable reality.